AIDS TREATMENT NEWS Issue #369, July 27, 2001
John S. James
The advance registration deadline has recently been extended to August 17. After that, persons should register onsite at the Philadelphia Marriott.
International press note: "Representatives from non-U.S. media are required to pre-register by Friday, August 24, 2001 in order to receive press credentials to attend the AIDS Vaccine 2001 conference. On-site media registration is not available for non-U.S. media due to the need to verify media credentials in advance" (quoted from the conference Web site, August 5). This has been a problem in at least one previous AIDS conference, as reporters are not used to registering in advance to cover news, and will often not learn of the requirement in time. We are concerned that international journalists may be turned away.
Program
The conference has more than 60 sessions. Talks include:
* The Global Need for an AIDS Vaccine (keynote talk in opening session)
* Lessons from Acute Infection and Relevance to Vaccine Development
* Innate Immunity
* Candidate Vaccines
* Access and Implementation
* Novel Envelope Immunogens
* Experience with AIDS Clinical Trials in Humans: What We've Learned
* Design, Oversight, and Review of Phase III Efficacy Trials
* Therapeutic Vaccines and Immune Response
* The Genesis of HIV Diversity
* Late Breaker and Innovative Strategies Session
In addition there are many poster sessions, mostly on technical topics.
For more information, see the conference Web site, http://www.aidsvaccine2001.org
010727
ATN36903
Copyright © 2001 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org http://www.aidsnews.org
Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207
ÆGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
ÆGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1990, 2000. ÆGIS. All materials appearing on ÆGIS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ÆGIS, or the party credited as the provider of the content. Feedback/Contact Us.